Arysta Lifescience India Limited

Arysta Lifescience India Limited - agriculture in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51420MH1949PLC007856 Incorporated 07 November 1949 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company agriculture
Data last updated
Revenue · FY 2023
₹1,689.48 Cr
▲ 38% YoY
Net profit · FY 2023
₹123.42 Cr
Net margin 7.3%
EBITDA · FY 2023
₹167.52 Cr
EBITDA margin 9.9%
Authorised capital
₹105 Cr
Registered with MCA
Paid-up capital
₹4.98 Cr
Issued & subscribed
Company age
77 yrs
Est. 1949
Employees · EPFO
254
Provident fund records
Directors on board
5
As per MCA filings

About Arysta Lifescience India Limited

Data last updated:

Arysta Lifescience India Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Arysta Lifescience (Mauritius) Ltd.. It operates in the crop protection segment of the agriculture sector. It was incorporated on 07 November 1949 and has been in existence for over 77 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51420MH1949PLC007856. Its GSTIN is 27AAACD0557C1Z5 (Maharashtra). The company holds 24 GST registrations, of which 11 are active.

The company has an authorised share capital of ₹105 Cr and a paid-up capital of ₹4.98 Cr. It was formerly known as Devidayal (Sales) Limited. It is led by directors including Sameer Tandon and Meena Deepak Ved.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Uniphos House 11th Road Opp Madhu Park Khar (W), Mumbai, Maharashtra, India – 400052.

As per the financials filed for FY 2023, the company reported a revenue of ₹1,689.48 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹123.42 Cr (net margin 7.3%) and EBITDA of ₹167.52 Cr (EBITDA margin 9.9%). Revenue has grown at a compounded annual rate (CAGR) of 106% over three years and 60% over five years.

The company has about 254 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Arysta LifeScience. Court records list 2,267 cases involving the company, including 2,186 filed by the company and 81 filed against it; 33 cases are pending. The company has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹2.1 Cr; the latest was in March 2017. Its 6 peer companies in the Business Services industry (Business Auxiliary Services, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is GSP Crop Science Limited with revenue of ₹1,301.06 Cr. The company has 11 MSME Form 1 returns on record between 2021 and 2024, listing 608 overdue payments to 108 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arystalifescience.com.

Company details

CIN U51420MH1949PLC007856
Registration Number 007856
Incorporation Date 07 November 1949
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Arysta Lifescience (Mauritius) Ltd.
Compliance Status Active Compliant

CIN history

Arysta Lifescience India has one previous CIN (Corporate Identification Number): U51420MH1949PTC007856. The current CIN is U51420MH1949PLC007856, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51420MH1949PLC007856Current
U51420MH1949PTC007856Previous

Contact details

Arysta Lifescience India Limited's registered office is in Mumbai, Maharashtra. Its website is arystalifescience.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Uniphos House 11th Road Opp Madhu Park Khar (W), Mumbai, Maharashtra, India – 400052
  • Industry
    Agriculture, Crop Protection

To see the full contact details of Arysta Lifescience India Limited, buy the company report.

Comprehensive company report
Arysta Lifescience India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Arysta Lifescience India operates one associated brand: Arysta LifeScience. Each brand links to its own profile.

BrandDescriptionWebsite
Chemical and bio-fertilizers are produced and supplied by the company.arystalifescience.com

Business activity

The main business activity of Arysta Lifescience India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Arysta Lifescience India Limited, buy the company report.

Financials of Arysta Lifescience India Limited

FY 2025 filings available

Arysta Lifescience India Limited reported revenue of ₹1,689.48 Cr (up 38% YoY) for FY 2023.

Revenue · FY 2023
₹1,689.48 Cr ▲ 38%
Net profit · FY 2023
₹123.42 Cr margin 7.3%
EBITDA · FY 2023
₹167.52 Cr margin 9.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 106%
5 years · compounded
▲ 60%
EBITDA CAGR growth
1 year
▲ 138%
3 years · compounded
▲ 174%
5 years · compounded
▲ 81%

Revenue has grown at a compounded annual rate (CAGR) of 60% over five years, including 38% growth in the latest year. EBITDA rose 138% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1,689.48 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹167.52 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹123.42 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin9.9%
Net Profit Margin7.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arysta Lifescience India Limited, buy the company report.

Board of directors of Arysta Lifescience India Limited

Arysta Lifescience India has 5 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ravishankar CherukuriAdditional Director17 Nov 20250 Years 11 MonthsCurrent
Sameer TandonDirector13 Jan 20206 Years 9 MonthsCurrent
Meena Deepak VedDirector18 May 20206 Years 5 MonthsCurrent
Swati Sandesh MayekarDirector18 May 20206 Years 5 MonthsCurrent
Ashish DobhalDirector07 Jul 20197 Years 3 MonthsCurrent

Peer comparison

Arysta Lifescience India Limited is compared with the 6 companies closest to it by revenue in the Business Services industry (Business Auxiliary Services, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Arysta Lifescience India Limitedthis company₹1,689.48 Cr (FY 2023)₹123.42 Cr7.3%38.0%254Mumbai, Maharashtra, India
GSP Crop Science Limited₹1,301.06 Cr (FY 2025)12.0%Ahmedabad, Gujarat, India
Nacl Industries Limited₹1,242.56 Cr (FY 2025)-30.0%Hyderabad, Telangana, India
SML Limited₹1,214.37 Cr (FY 2025)5.0%Mumbai, Maharashtra, India
Cheminova India Limited₹1,205.86 Cr (FY 2025)-50.0%Mumbai, Maharashtra, India
Bharat Rasayan Limited₹1,199.03 Cr (FY 2025)13.0%New Delhi, Delhi, India
Corteva Crop India Private Limited₹1,175.36 Cr (FY 2025)16.0%Hyderabad, Telangana, India

To see the full peer comparison of Arysta Lifescience India Limited, buy the company report.

Auditor

Arysta Lifescience India Limited is audited by B S R & Co. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R & Co. LLPFY 2023101248W/W-100022

Shareholding

The shareholding of Arysta Lifescience India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Arysta Lifescience India Limited, buy the company report.

Deals & funding

Arysta Lifescience India Limited has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹2.1 Cr; the latest was in March 2017.

Total deals
9
Secondary share transfers
8
Funding round
1
Disclosed funding
₹2.1 Cr

Deals on record (5 of 9)

WhenDealAmountParties
Mar 2017Funding round₹2.1 CrInvestors: Upl Agricultural Solutions Holdings Bv, Macdermid Agricultural Solutions Holding B V & Hema Rani
May 2013Secondary share transferUndisclosedSeller: Arysta LifeScience (Mauritius) Limited
Jan 2012Secondary share transferUndisclosedBuyer: Arysta LifeScience (Mauritius) Limited, Arysta Lifescience Canada BC, Inc
Seller: Arysta LifeScience (Mauritius) Limited, 3 individuals
Mar 2011Secondary share transferUndisclosedBuyer: Arysta LifeScience (Philippines) Inc, Arysta LifeScience Canada Inc, Arysta LifeScience (Mauritius) Limited
Seller: 4 individuals
Oct 2010Secondary share transferUndisclosedBuyer: an individual
Seller: Agastya Udyog Company

To see the full deal history of Arysta Lifescience India Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Arysta Lifescience India Limited has 11 MSME Form 1 returns on record between 2021 and 2024, listing 608 overdue payments to 108 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 108)

SupplierAmount dueDue sinceReported on
Vora & Associates
Colour India
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Arysta Lifescience India Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Arysta Lifescience India Limited has a workforce of 254 employees on its EPFO records as of Apr 08, 2024, across 2 active EPFO establishments.

Employee count
254
Active EPFO establishments
2
Employee growth
535%

GST

Arysta Lifescience India has 24 GST registrations: 11 active and 13 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
24
Active
11
Cancelled / inactive
13
GSTINStateStatusRegistered on
27AAACD0557C1Z5MaharashtraActive01 Jul 2017
27AAACD0557C2Z4MaharashtraActive26 Feb 2025
03AAACD0557C1ZFPunjabActive01 Jul 2017
06AAACD0557C1Z9HaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Arysta Lifescience India Limited, buy the company report.

Recent activity

Arysta Lifescience India Limited has 22 board changes on record since 2011: 5 appointments and 17 cessations. The latest: Ravishankar Cherukuri was appointed as Additional Director on 17 Nov 2025.

Appointed
Ravishankar Cherukuri was appointed as Additional Director.
AGM
Arysta Lifescience India Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Arysta Lifescience India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Meena Deepak Ved ceased to be Additional Director.
Ceased
Sameer Tandon ceased to be Additional Director.
Ceased
Swati Sandesh Mayekar ceased to be Additional Director.
Appointed
Meena Deepak Ved was appointed as Director.
Appointed
Swati Sandesh Mayekar was appointed as Director.
Ceased
Sujata Chattopadhyay ceased to be Director.
Appointed
Sameer Tandon was appointed as Director.
Ceased
Hema Rani ceased to be Company Secretary.
Ceased
Arun Chandrasen Ashar ceased to be Additional Director.

13 earlier events are in the company report.

Frequently asked questions

Arysta Lifescience India is an active public limited company based in Mumbai, Maharashtra, India. The company works in crop protection, within the agriculture industry. It was incorporated on 07 November 1949 (77+ years old) and is registered under CIN U51420MH1949PLC007856.

Arysta Lifescience India has 5 current directors:

The latest financial statements of Arysta Lifescience India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Arysta Lifescience India is 27AAACD0557C1Z5, registered in Maharashtra. The company has 24 GST registrations in all, of which 11 are active and 13 are cancelled or inactive. Other active GSTINs include 27AAACD0557C2Z4 (Maharashtra), 03AAACD0557C1ZF (Punjab), 06AAACD0557C1Z9 (Haryana).

The CIN (Corporate Identification Number) of Arysta Lifescience India is U51420MH1949PLC007856. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arysta Lifescience India has 2,267 court cases on record: 2,186 filed by the company and 81 filed against it. 33 are pending. Most are in the district courts.

Arysta Lifescience India was incorporated on 07 November 1949, making it 77+ years old. It is registered with the Registrar of Companies, Mumbai.

Arysta Lifescience India has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹2.1 Cr; the latest was in March 2017.

The peers of Arysta Lifescience India by revenue are GSP Crop Science Limited, Nacl Industries Limited, SML Limited, Cheminova India Limited, Bharat Rasayan Limited and 1 more, all in the Business Services industry (Business Auxiliary Services, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ravishankar Cherukuri was appointed as Additional Director on 17 Nov 2025. Meena Deepak Ved ceased to be Additional Director on 30 Sep 2020. Sameer Tandon ceased to be Additional Director on 30 Sep 2020. Arysta Lifescience India has 22 board changes on record in total.

Arysta Lifescience India has 11 MSME Form 1 returns on record between 2021 and 2024, listing 608 overdue payments to 108 micro and small suppliers. The latest return was filed on 22 Apr 2024.

Arysta Lifescience India can be reached through the website arystalifescience.com. Its registered office is in Mumbai, Maharashtra, India.